MedTrace Logo

Sympathetic Transduction in Obesity

NCT05590546 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2024-10-03

No results posted yet for this study

Summary

Central (abdominal) obesity is associated with elevated adrenergic activity and arterial blood pressure (BP). Therefore, we tested the hypothesis that transduction of spontaneous muscle sympathetic nerve activity (MSNA) to BP, i.e., sympathetic transduction, is augmented in abdominal obesity (increased waist circumference) and positively related to prevailing BP.

Conditions

Interventions

OTHER

No intervention

No intervention, only performing cross-sectional analysis of pooled data collected in previous studies

Sponsors & Collaborators

  • University of Kansas Medical Center

    lead OTHER

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-10-01
Primary Completion
2026-11-19
Completion
2026-12-19

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05590546 on ClinicalTrials.gov